Literature DB >> 26850360

Serum immune biomarkers in irritable bowel syndrome.

Seyedmehdi Seyedmirzaee1, Mohammad Mahdi Hayatbakhsh2, Bizhan Ahmadi3, Nadieh Baniasadi4, Afshin Mohammad Bagheri Rafsanjani5, Amin Reza Nikpoor6, Mojgan Mohammadi7.   

Abstract

BACKGROUND AND OBJECTIVES: Irritable bowel syndrome (IBS) is the most prevalent functional gastrointestinal (GI) disorder, which presents with abdominal pain and changes in the bowel habits. Although the exact cause of IBS remains uncertain, some studies have shown that the inflammation and cytokine imbalance may act as potential etiological factors. The aim of our study is to compare the serum levels of interleukin 6 (IL-6), interleukin 8 (IL-8), and tumor necrosis factor-alpha (TNF-α) in patients with IBS with the healthy controls. The other aim of this study is to evaluate possible association between above-mentioned cytokines and IBS subtypes.
METHODS: Seventy-four IBS patients diagnosed based on Rome III criteria and 75 gender and age-matched healthy controls were included in this study. Cytokines were measured in the serum using enzyme-linked immunosorbent assays (ELISA).
RESULTS: Patients were classified into groups of IBS with diarrhea (IBS-D): 34, IBS with constipation (IBS-C): 29, and IBS with mixed symptoms (IBS-M): 11. The serum levels of IL-6, IL-8 and TNF-α were significantly higher in patients with IBS as compared to controls (P<0.001). There was no difference in serum levels of cytokines based on IBS subtypes.
CONCLUSIONS: Higher serum level of IL-6, IL-8 and TNF-α in IBS suggests an important role of cytokines as immune mediators in the pathogenesis of this functional GI disorder. To understand any association between cytokines and IBS subtypes, further investigations with larger sample sizes are desired.
Copyright © 2016. Published by Elsevier Masson SAS.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26850360     DOI: 10.1016/j.clinre.2015.12.013

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN: 2210-7401            Impact factor:   2.947


  25 in total

1.  Immune Activation in Functional Gastrointestinal Disorders.

Authors:  Grace Burns; Jennifer Pryor; Gerald Holtmann; Marjorie M Walker; Nicholas J Talley; Simon Keely
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-10

2.  Elevated serum neopterin levels in children with functional constipation: association with systemic proinflammatory cytokines.

Authors:  Ceren Cıralı; Emel Ulusoy; Tuncay Kume; Nur Arslan
Journal:  World J Pediatr       Date:  2018-03-16       Impact factor: 2.764

3.  The Serum Levels of CCL2 and CCL16 Expression in Patients with Irritable Bowel Syndrome.

Authors:  Mohammad Mahdi Hayatbakhsh; Arezoo Gowhari Shabgah; Saeed Pishgouyi; Jalil Tavakol Afshari; Hadi Zeidabadi; Mojgan Mohammadi
Journal:  Rep Biochem Mol Biol       Date:  2019-04

Review 4.  Crosstalk between Inflammation and ROCK/MLCK Signaling Pathways in Gastrointestinal Disorders with Intestinal Hyperpermeability.

Authors:  Lijun Du; John J Kim; Jinhua Shen; Ning Dai
Journal:  Gastroenterol Res Pract       Date:  2016-09-26       Impact factor: 2.260

Review 5.  Non-celiac gluten sensitivity: All wheat attack is not celiac.

Authors:  Samuel O Igbinedion; Junaid Ansari; Anush Vasikaran; Felicity N Gavins; Paul Jordan; Moheb Boktor; Jonathan S Alexander
Journal:  World J Gastroenterol       Date:  2017-10-28       Impact factor: 5.742

6.  Characteristics of IL-9 induced by Schistosoma japonicum infection in C57BL/6 mouse liver.

Authors:  Lu Li; Hongyan Xie; Mei Wang; Jiale Qu; Hefei Cha; Quan Yang; Yuanfa Feng; Yanwei Qi; Huaina Qiu; Nuo Dong; Jun Huang
Journal:  Sci Rep       Date:  2017-05-24       Impact factor: 4.379

7.  Increased serum interleukin-6 levels in patients with hidradenitis suppurativa.

Authors:  Haoxiang Xu; Xuemin Xiao; Yanyan He; Xiaofeng Zhang; Chengrang Li; Qiuxia Mao; Xinfeng Wu; Baoxi Wang
Journal:  Postepy Dermatol Alergol       Date:  2017-02-07       Impact factor: 1.837

8.  Cytokine Levels and Symptoms Among Women with Irritable Bowel Syndrome: Considering the Role of Hormonal Contraceptive Use.

Authors:  Kendra J Kamp; Claire Han; Robert J Shulman; Kevin C Cain; Pamela Barney; Mark R Opp; Lin Chang; Robert L Burr; Margaret M Heitkemper
Journal:  Biol Res Nurs       Date:  2020-07-17       Impact factor: 2.522

9.  Butyrate Alleviates Cytokine-Induced Barrier Dysfunction by Modifying Claudin-2 Levels.

Authors:  Xinyi Huang; Tadayuki Oshima; Toshihiko Tomita; Hirokazu Fukui; Hiroto Miwa
Journal:  Biology (Basel)       Date:  2021-03-09

10.  Functional Bowel Disorders Are Associated with a Central Immune Activation.

Authors:  Per G Farup; Thor Ueland; Knut Rudi; Stian Lydersen; Knut Hestad
Journal:  Gastroenterol Res Pract       Date:  2017-10-23       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.